Deletion of eNOS diminishes estrogen-derived protective effects in female mice of diabetic nephropathy (47) and accelerates the progress in streptozotocin-induced type 1 diabetic mice (5). This evidence concerns the gene NOS3 and type 1 diabetes mellitus.